Rafina Innovations Revenue Growth Rates (VICA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Rafina Innovations Inc.  (VICA)
 

VICA's Revenue Growth by Quarter and Year

Rafina Innovations's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VICA Revenue (in millions $) FY 2019 FY 2018 FY 2017 FY 2016
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.05
FY 0.05

VICAs Annual Revenue
Rafina Innovations's Revenue in the fiscal year 2018 $ 0.41 millions
Rafina Innovations's Revenue in the fiscal year 2017 $ 0.36 millions
Rafina Innovations's Revenue in the fiscal year 2016 $ 0.69 millions
Rafina Innovations's Revenue in the fiscal year 2015 $ 0.06 millions
Rafina Innovations's Revenue in the fiscal year 2014 $ 0.03 millions




VICA Revenue first quarter 2019 Y/Y Growth Comment
Rafina Innovations Inc. reported drop in Revenue in the first quarter 2019 by -58.27% to $ 0.05 millions, from the same quarter in 2018.
The fall in the first quarter 2019 Rafina Innovations Inc.'s Revenue compares unfavorably to the Company's average Revenue doubling of 333.67%.

Looking into first quarter 2019 results within Medical Equipment & Supplies industry 173 other companies have achieved higher Revenue growth. While Rafina Innovations Inc.' s Revenue meltdown of -58.27% ranks overall at the positon no. 4314 in the first quarter 2019.


VICA Revenue ( Y/Y Growth %) 2019
 2018 2017 2016
4th Quarter December - 0 % 125 % 300 %
3rd Quarter September - 80 % -89.13 % 2200 %
2nd Quarter June - -23.08 % 160 % 66.67 %
1st Quarter March -58.27 % 44.44 % -35.71 % 1300 %
FY   - 13.89 % -47.83 % -

Financial Statements
Rafina Innovations's first quarter 2019 Revenue $ 0.05 millions VICA's Income Statement
Rafina Innovations's first quarter 2018 Revenue $ 0.13 millions Quarterly VICA's Income Statement


VICA Revenue (Quarter on Quarter Growth %)

 2019
 2018 2017 2016
4th Quarter December - 0 % 80 % -91.3 %
3rd Quarter September - -10 % -61.54 % 820 %
2nd Quarter June - -23.08 % 44.44 % -64.29 %
1st Quarter March -39.72 % 44.44 % 125 % 1300 %
FY (Year on Year)   - 13.89 % -47.83 % -


Back to VICA Growth rate Comparisons >> Back to VICA Growth rate Comparisons >>


Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #174
Healthcare Sector #595
Overall #4314

Revenue Y/Y Growth Statistics
High Average Low
2541.83 % 333.67 % -89.16 %
(Sep 30 2016)   (Sep 30 2017)
Revenue first quarter 2019 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #174
Healthcare Sector #595
Overall #4314
Revenue Y/Y Growth Statistics
High Average Low
2541.83 % 333.67 % -89.16 %
(Sep 30 2016)   (Sep 30 2017)

Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Rafina Innovations's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
2515.3 % 215.91 % -92.41 %
(Mar 31 2016)  


VICA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Rafina Innovations Inc. disclosed fall in Revenue from the fourth quarter by -39.72% to $ 0.05 millions, from $ 0.09 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2019 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 141 other companies have achieved higher Revenue quarter on quarter growth. While Rafina Innovations's Revenue growth quarter on quarter, overall rank is 3606.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #142
Healthcare Sector #459
Overall #3606
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #142
Healthcare Sector #459
Overall #3606
Revenue Q/Q Growth Statistics
High Average Low
2515.3 % 215.91 % -92.41 %
(Mar 31 2016)  


VICA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2019 Rafina Innovations Inc. disclosed fall in Revenue from the fourth quarter by -39.72% to $ 0.05 millions, from $ 0.09 millions achived in the previous reporting period.

Although periodic circumstance commonly energize I. Quarter 2019 Revenue, this plainly could not be substantial to rescue 's company achievement, Most analysts pointed out.

Within Medical Equipment & Supplies industry 141 other companies have achieved higher Revenue quarter on quarter growth. While Rafina Innovations's Revenue growth quarter on quarter, overall rank is 3606.


Rafina Innovations's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2019)		 12 Months Ending
(Dec 31 2018)		 12 Months Ending
(Sep 30 2018)		 12 Months Ending
(Jun 30 2018)		 12 Months Ending
(Mar 31 2018)
Cumulative Revenue 12 Months Ending $ 0.34 $ 0.41 $ 0.41 $ 0.37 $ 0.40
Y / Y Revenue Growth (TTM) -16.44 % 16.01 % 34.74 % -48.47 % -36.68 %
Year on Year Revenue Growth Overall Ranking # 3588 # 0 # 614 # 3327 # 3051
Seqeuential Revenue Change (TTM) -18.79 % 0.39 % 11.07 % -7.72 % 12.75 %
Seq. Revenue Growth (TTM) Overall Ranking # 1359 # 3794 # 473 # 3452 # 3434


Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2019 Rafina Innovations reported a fall in Revenue by -16.44% year on year, to $0 millions, compare to the 16.01% growth at Dec 31 2018.

In the Healthcare sector 451 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3588.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 452
Overall # 3588

Revenue TTM Y/Y Growth Statistics
High Average Low
1043.44 %
 136.27 %
-53.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 237
S&P 500 # 1359
Cumulative Revenue growth Comment
For the 12 months ended Mar 31 2019 Rafina Innovations reported a fall in Revenue by -16.44% year on year, to $0 millions, compare to the 16.01% growth at Dec 31 2018.

In the Healthcare sector 451 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 0 to 3588.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 60
Healthcare Sector # 452
Overall # 3588

Revenue TTM Y/Y Growth Statistics
High Average Low
1043.44 %
136.27 %
-53.61 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 60
Sector # 237
S&P 500 # 1359




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VICA's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Mar 31 2019 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2019
Surgery Partners Inc -0.14%$ -0.136 millions
Luminex Corporation-0.31%$ -0.307 millions
Hutchmed china Limited-0.32%$ -0.323 millions
Sonida Senior Living Inc -0.41%$ -0.407 millions
Ironwood Pharmaceuticals inc -0.61%$ -0.615 millions
Becton Dickinson And Company-0.64%$ -0.640 millions
Elanco Animal Health Incorporated-0.69%$ -0.693 millions
Alkermes Plc -0.91%$ -0.910 millions
Dentsply Sirona Inc -1.04%$ -1.035 millions
Abbvie Inc -1.34%$ -1.336 millions
Utah Medical Products Inc-1.42%$ -1.424 millions
American Renal Associates Holdings Inc -1.49%$ -1.495 millions
Phibro Animal Health Corporation-1.52%$ -1.518 millions
Sorrento Therapeutics Inc -1.65%$ -1.649 millions
Catalent Inc -1.66%$ -1.656 millions
Baxter International Inc -1.68%$ -1.681 millions
Allied Healthcare Products inc -1.78%$ -1.781 millions
Jounce Therapeutics inc -1.79%$ -1.786 millions
Envista Holdings Corporation-1.92%$ -1.918 millions
Labcorp Holdings Inc -2.00%$ -2.005 millions
Allergan plc-2.04%$ -2.042 millions
Zimmer Biomet Holdings Inc -2.09%$ -2.087 millions
Arvinas Inc -2.24%$ -2.242 millions
Elite Health Systems Inc -2.77%$ -2.775 millions
Waters Corporation-3.17%$ -3.167 millions
Procyon Corporation-3.27%$ -3.269 millions
Tenet Healthcare Corp-3.28%$ -3.277 millions
Cellular Biomedicine Group Inc -3.33%$ -3.328 millions
Enveric Biosciences Inc -3.41%$ -3.406 millions
Perrigo Company Plc-3.49%$ -3.492 millions


About Rafina Innovations Revenue Growth Rates (VICA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.